1OLOBO J O, GELETU M, DEMISSIE A, et al. Circulating TNF - alpha, TGF - beta, and IL - 10 in tuberculosis patients and healthy contacts[J]. Scand J Immunol,2001,53(1):85-91.
2CHENG D, LEE Y C, ROGERS J T, et al. Vascular endothelial growth factor level correlates with transforming growth factor- beta isoform levels in pleural effusions[J]. Chest,2000,118(6): 1 747- 1 753.
3MOBUS V J, MOLL R, GERHARZ C D, et al. Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin [J]. Int J Cancer, 1998,77(3):415 -423.
4ISHIMOTOO,SAUOY, NARUMIK, etal. High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer[J].Oncology,2002,63(1):70-75.
5STRIZZIL, VIANALEG,CATALANOA,et al. Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis[J]. Int J Oncol,2001,18(5) :1 093- 1 098.
2Hanahan D, Folkman J. Patterns and emerging mechannisms of theangiogenic switch during tumorigenesis. Cell, 1996,86 ( 4 ) : 353.
3Yamamoto Y ,Toi M, Kondo S,et al. Concentrations of vascularendothelial growth factor in sera of nomal controls and cancer pa- tients. Clin Cancer Res,1996,2(7) :821.
4Demirkesen AC, Evrendilek F, Berberoglu S, et al. Coastal flood risk analysis using landsat 27 ETM + imagery and SRTMDEM : a case study of lzmir, Turkey. Environ Monit Assess, 2007, 131 (6) :293-300.
5Terada T, Mizobata M, Kawakami S, et al. Optimization of tumor2selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. J Control Release, 2007, 119 (5) : 262-270.
6Hajime M, Shuichi Y, Makoto N, et al. Inhibitory effect of 4-methylesculetin on hyaluronan synthesis slows the development of human pancreatic cancer invitro and in nude mice. Int J Cancer, 2007,120 ( 5 ) :2704-2709.
7Ostap M, Mare A, Shuman MA, et al. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from itseffect on primary tumor growth. Cancer Res, 1996,56 (8) :921.
